Fig. 7
From: The value of acetylation reader YEATS2 in hepatocellular carcinoma management
Impact of YEATS2 on Various HCC Treatments. (A) Evaluate the impact of YEATS2 on sensitivity to chemotherapy drugs in liver cancer via GDSC1 analysis. (B) MTT assay to assess cisplatin resistance. (B, C) Analyze the influence of YEATS2 on HCC chemosensitivity using GDSC2 and CTRP datasets, respectively. (E-F) Explore YEATS2 expression differences in varying radiotherapy outcomes and MVI presence post-surgery across diverse datasets. (G-H) Analyze YEATS2’s effect on TACE efficacy and validate the correlation between serum YEATS2 levels and TACE response. (I-J) Assess YEATS2’s influence on sorafenib efficacy in HCC patients, complemented by MTT assays examining YEATS2’s role in HCC cell sorafenib resistance.
